Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells

被引:0
|
作者
Cobbs, CS
Whisenhunt, TR
Wesemann, DR
Harkins, LE
Van Meir, EG
Samanta, M
机构
[1] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA
[2] Vet Affairs Med Ctr, Surg Serv, Birmingham, AL USA
[3] Univ Alabama, Med Scientist Training Program, Birmingham, AL USA
[4] Emory Univ, Sch Med, Mol Neurooncol Lab, Atlanta, GA USA
[5] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are the most common primary brain tumors in adults, and the most malignant form, glioblastoma multiforme (GBM), is usually rapidly fatal. Most GBMs do not have p53 mutations, although the p53 tumor suppressor pathway appears to be inactivated. GBMs grow in a hypoxic and inflammatory microenviromnent, and increased levels of the free radicals nitric oxide (NO) and superoxide (O-2 radical anion,) occur in these malignancies in vivo. Peroxynitrite (ONOO-) is a highly reactive molecule produced by excess NO and W. that can posttranslationally modify and inactivate proteins, especially zinc finger transcription factors such as p53. We demonstrated previously that GBMs have evidence of tyrosine nitration, the "footprint" of per oxymtrite-mediated protein modification in vivo, and that peroxyrtitrite could inhibit the specific DNA binding ability of wild-type p53 protein in glioma cells in vitro. Here we show that both authentic peroxynitrite and SIN-1 (3-morpholinosydnonimine hydrochloride), a molecule that decomposes into NO and O-2 radical anion to form peroxynitrite, can inhibit wild-type p53 function in malignant glioma cells. Concentrations of peroxynitrite associated with a tumor inflammatory environment caused dysregulation. of wild-type p53 transcriptional activity and downstream p21(WAF1) expression.
引用
收藏
页码:8670 / 8673
页数:4
相关论文
共 50 条
  • [1] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [2] Transduction of a wild-type p53 gene into human malignant melanoma cells
    Hakim, AA
    CANCER GENE THERAPY, 2001, 8 : S8 - S8
  • [3] Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins
    Moos, PJ
    Edes, K
    Fitzpatrick, FA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) : 9215 - 9220
  • [4] Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells
    Satyamoorthy, K
    Chehab, NH
    Waterman, MJF
    Lien, MC
    El-Deiry, WS
    Herlyn, M
    Halazonetis, TD
    CELL GROWTH & DIFFERENTIATION, 2000, 11 (09): : 467 - 474
  • [5] Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene
    Lang, FF
    Yung, WKA
    Raju, U
    Libunao, F
    Terry, NHA
    Tofilon, PJ
    JOURNAL OF NEUROSURGERY, 1998, 89 (01) : 125 - 132
  • [6] Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells
    Unger, C
    Buchmann, A
    Buenemann, CL
    Kress, S
    Schwarz, M
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (01): : 87 - 95
  • [7] Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells
    Christina Unger
    Albrecht Buchmann
    Christoph L Bünemann
    Stefan Kress
    Michael Schwarz
    Cell Death & Differentiation, 1998, 5 : 87 - 95
  • [8] EFFECTS OF RESTORATION OF WILD-TYPE P53 EXPRESSION IN MALIGNANT KERATINOCYTES
    COURTOIS, SJ
    DEGREEF, H
    WOODWORTH, CD
    GARMYN, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) : 459 - 459
  • [9] ACCUMULATION OF WILD-TYPE P53 PROTEIN IN HUMAN ASTROCYTOMAS
    RUBIO, MP
    VONDEIMLING, A
    YANDELL, DW
    WIESTLER, OD
    GUSELLA, JF
    LOUIS, DN
    CANCER RESEARCH, 1993, 53 (15) : 3465 - 3467
  • [10] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887